National Institutes of Health: all 11,571 studies

Page 112 of 116. Open to participants first (945), then studies with results posted, then the rest; newest registration first within each.

• A Phase I Study of Safety and Pharmacokinetics of Nevirapine in HIV-1 Infected Pregnant Women and Neonates Born to HIV-1 Infected MothersCompletedNCT00000808Phase 1
• Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi's Sarcoma After Systemic ChemotherapyCompletedNCT00000807Phase 2
• A Phase I Randomized Dose/Formulation Comparison Study of SC-52151CompletedNCT00000806Phase 1
• A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus DiseaseCompletedNCT00000805Phase 1
• A Randomized Trial of L-735,524, An Inhibitor of the HIV Protease Enzyme, and Interleukin-2 in Persons Infected With HIV (NOTE: Only For Patients Who Previously Completed NIAID 93 CC-113)WithdrawnNCT00000804Not applicable
• A Phase II Double-Blind Study of Delavirdine Mesylate ( U-90152 ) in Combination With Zidovudine ( AZT ) and/or Didanosine ( ddI ) Versus AZT and ddI Combination TherapyCompletedNCT00000803Phase 2
• A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or SulfonamidesCompletedNCT00000802Phase 3
• Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System LymphomaCompletedNCT00000801Phase 2
• Methadone Effects on Zidovudine (ZDV, AZT) DispositionCompletedNCT00000800Phase 1
• HPMPC (Cidofovir) Peripheral CMV Retinitis Trial ProtocolCompletedNCT00000799Not applicable
• A Phase I Safety and Immunogenicity Trial of UBI Microparticulate Monovalent HIV-1 MN Peptide Immunogen in HIV-1 Seronegative Human SubjectsCompletedNCT00000798Phase 1
• Women's Interagency HIV Study (WIHS)Status unknownNCT00000797
• A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.CompletedNCT00000796Not applicable
• A Phase I Safety and Immunogenicity Trial of UBI Multivalent HIV-1 Peptide Immunogen in HIV-1 Seronegative Human SubjectsCompletedNCT00000795Phase 1
• Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic EncephalitisCompletedNCT00000794Phase 2
• A Phase II/III Double-Blind Study of Amitriptyline and Mexiletine for Painful Neuropathy in HIV InfectionCompletedNCT00000793Phase 2
• A Pharmacologically Guided Phase I/II Study of Daily Orally Administered Synthetic Hypericin in HIV-Infected SubjectsCompletedNCT00000792Phase 1
• A Phase II Double-Blind Study of Two Doses of SC-49483 in Combination With Zidovudine (ZDV) Versus ZDVCompletedNCT00000791Phase 2
• Thalidomide for Treatment of Oral and Esophageal Aphthous Ulcers and HIV Viremia in Patients With HIV InfectionCompletedNCT00000790Phase 2
• A Randomized, Comparative Trial of Zidovudine (AZT) Versus 2',3'-Didehydro-3'-Deoxythymidine (Stavudine; d4T) in Children With HIV InfectionCompletedNCT00000789Phase 2
• A Study to Assess the Effect of Concomitant Administration of Fluconazole on the Clinical Pharmacokinetics of MethadoneCompletedNCT00000788Phase 1
• Heterosexual HIV Transmission Study (HATS). Prospective Cohort StudyCompletedNCT00000787Not applicable
• A Registry of Tuberculosis Cases in the CPCRACompletedNCT00000785
• A Study of Psychosocial and Behavioral Determinants of Differential Rates of Participant Compliance in CPCRA ProtocolsCompletedNCT00000784
• Heterosexual HIV Transmission Study (HATS)CompletedNCT00000783
• A Phase I/II Study of Delayed-Type Hypersensitivity (DTH) Reactions to Intradermal HIV Envelope AntigenCompletedNCT00000782Phase 1
• A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3)CompletedNCT00000781Phase 2
• A "Pre-Enrollment" Protocol for HIV-Infected AdolescentsCompletedNCT00000780
• A Phase I Comparative Blinded Trial of Several HIV-1 Derived Immunogens in Infected Individuals With >= 500 CD4 Cells/mm3CompletedNCT00000779Phase 1
• A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and LevofloxacinCompletedNCT00000778Phase 1
• Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of VaxSyn Recombinant gp160 (NOTE: Some Patients Receive Placebo)CompletedNCT00000777Phase 1
• Dexamethasone in Cryptococcal MeningitisCompletedNCT00000776Phase 2
• A Phase I Safety and Immunogenicity Trial of UBI SynVac (HIV-1 MN Octameric V3 Peptide Vaccine)CompletedNCT00000775Phase 1
• A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected MothersCompletedNCT00000774Phase 1
• Phase I Safety and Pharmacokinetics Study of Microparticulate Atovaquone (m-Atovaquone; 566C80) in HIV-Infected and Perinatally Exposed Infants and ChildrenCompletedNCT00000773Phase 1
• A Phase I Open-Label Study of the Safety, Tolerance, and Pharmacokinetic Interactions of Combination Didanosine and Ribavirin in HIV-Positive IndividualsCompletedNCT00000772Phase 1
• A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cells/mm3CompletedNCT00000771Phase 2
• A Comparative Study of a Combination of Zidovudine, Didanosine, and Double-Blinded Nevirapine Versus a Combination of Zidovudine and DidanosineCompletedNCT00000770Phase 2
• A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's SarcomaCompletedNCT00000769Phase 1
• A Randomized Comparative Pharmacokinetic Study of Oral Ganciclovir After Treatment With Intravenous Ganciclovir for Cytomegalovirus Gastrointestinal Disease in AIDS PatientsCompletedNCT00000768Phase 1
• A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV-1 IIIB Env/Gag/Pol Vaccine (TBC-3B)CompletedNCT00000767Phase 1
• CMV Retinitis Retreatment TrialCompletedNCT00000766Phase 2
• Pilot Study to Evaluate the Efficacy of Zidovudine in Preventing CD4+ Lymphocyte Decline in Patients With Primary HIV Infection. (One Treatment Arm Receives Placebo)CompletedNCT00000765Not applicable
• Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection.CompletedNCT00000764Phase 1
• A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposi's SarcomaCompletedNCT00000763Phase 1
• A Placebo-Controlled, Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Envelope Proteins of HIV-1 gp160 and gp120 in Children >= 1 Month Old With Asymptomatic HIV InfectionCompletedNCT00000762Phase 1
• Phase I/II Study of Recombinant Human Interferon-gamma (rIFN-gamma) in HIV-Infected ChildrenCompletedNCT00000761Phase 1
• A Randomized Study of Activity, Safety, and Tolerance of Oral Ro 24-7429 (Tat Antagonist) in Patients With HIV InfectionCompletedNCT00000760Phase 1
• Neurodevelopmental and Neurological Study of Infants and Children With HIV-1 Infection and AIDS in Clinical TrialsCompletedNCT00000759
• A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected WomenCompletedNCT00000758Phase 3
• A Phase I Multicenter Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160CompletedNCT00000757Phase 1
• Evaluation of the Safety and Tolerance of Immunotherapy With Autologous, Ex-Vivo Expanded, HIV-Specific Cytotoxic T-Cells in HIV-Infected Patients With CD4+ Counts Between 100-400/mm3CompletedNCT00000756Phase 1
• A Phase I/II Trial of Vaccine Therapy of HIV-1 Infected Individuals With 50-500 CD4 Cells/mm3CompletedNCT00000755Phase 1
• A Randomized Phase II Study of Two Doses of Interferon Alfa-2a (IFN Alfa-2a) in Combination With Zidovudine (AZT) and Dideoxycytidine (ddC) Versus AZT and ddC Only in Patients With HIV Infection and Less Than 400 CD4 Cells/mm3CompletedNCT00000754Phase 2
• A Phase I Concentration-Targeted Multidose Study of Atevirdine Mesylate ( U-87201E ), AZT, and ddI or ddCCompletedNCT00000753Phase 1
• Preventing Frequent Sinus Infections in HIV-Infected PatientsWithdrawnNCT00000752Phase 2
• A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)CompletedNCT00000751Phase 3
• A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV InfectionCompletedNCT00000750Phase 3
• A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 200 Mcg of gp120 (CHO) BIOCINE in MF59 Emulsion Versus the Emulsion Control: Three Injections at 0, 1, and 6 MonthsCompletedNCT00000749Phase 1
• A Randomized, Comparative, Prospective Study of Daily Trimethoprim / Sulfamethoxazole (TMS) and Thrice-Weekly TMS for Prophylaxis Against PCP in HIV-Infected PatientsCompletedNCT00000748Phase 3
• An Open-Label, Pilot Study to Evaluate the Development of Resistance to Nevirapine (BI-RG-587) in HIV-Infected Patients With CD4 Cell Count >= 500/mm3CompletedNCT00000747Phase 2
• A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope VaccinesCompletedNCT00000746Phase 1
• A Phase I Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160CompletedNCT00000745Phase 1
• A Randomized, Prospective, Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected WomenCompletedNCT00000744Not applicable
• A Phase I, Dose-Escalating Safety and Tolerance Study of sCD4-PE40 in HIV-Infected PersonsCompletedNCT00000743Phase 1
• A Phase I Concentration-Controlled Trial to Assess the Safety, Tolerance, Pharmacokinetics and Development of Decreased HIV-1 Susceptibility to the Combination of Atevirdine Mesylate (U-87201E), Zidovudine (AZT), and Didanosine (ddI)CompletedNCT00000742Phase 1
• The Safety and Effectiveness of Methylprednisolone in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Children With AIDSWithdrawnNCT00000741Phase 3
• Escalating Multiple-Dose Safety and Tolerance of WR 6026 Hydrochloride in HIV-Infected SubjectsCompletedNCT00000740Phase 1
• Comparison of Two Dosage Regimens of Oral Dapsone for Prophylaxis of Pneumocystis Carinii Pneumonia in Pediatric HIV InfectionCompletedNCT00000739Phase 1
• Randomized, Double-Blind, Placebo-Controlled Trial of Nimodipine for the Neurological Manifestations of HIV-1CompletedNCT00000738Phase 1
• A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting SyndromeCompletedNCT00000737Phase 1
• Safety and Efficacy of Zidovudine for Asymptomatic HIV-Infected IndividualsCompletedNCT00000736Phase 3
• A Clinical Trial To Evaluate the Toxicity and Antiviral Effects of a Range of Doses of Ampligen in p24 Antigen Positive HIV-Infected Patients With AIDS or ARCCompletedNCT00000735Phase 1
• Evaluation of the Interaction Between High Dose Sulfamethoxazole/Trimethoprim and ZidovudineCompletedNCT00000734Not applicable
• Phase I Pharmacokinetic and Tolerance Study of Ribavirin in Human Immunodeficiency Virus (HIV) - Infected PatientsCompletedNCT00000733Phase 1
• Evaluation of the Interaction Between Low Dose Sulfamethoxazole-Trimethoprim and ZidovudineCompletedNCT00000732Not applicable
• Evaluation of the Interaction Between Acetaminophen and ZidovudineCompletedNCT00000731Not applicable
• Comparison of Three Treatments for Pneumocystis Pneumonia in AIDS PatientsTerminatedNCT00000730Phase 3
• A Multicenter Study To Determine Foscarnet Dose Response in HIV Infected Patients With PGL and/or Constitutional DiseaseCompletedNCT00000729Phase 1
• Phase I Trial of the Combination of Zidovudine and Recombinant Interleukin-2 in Patients With Persistent Generalized LymphadenopathyCompletedNCT00000728Phase 1
• A Controlled Comparative Trial of Sulfamethoxazole-Trimethoprim Versus Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients Receiving Azidothymidine (AZT)CompletedNCT00000727Phase 3
• Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency SyndromeCompletedNCT00000726Phase 1
• A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's SarcomaCompletedNCT00000725Phase 1
• A Study of Trimetrexate With Leucovorin Rescue for AIDS Patients Who Are Refractory to Standard Therapies for Pneumocystis Carinii PneumoniaCompletedNCT00000724Phase 3
• The Use of Chemotherapy Plus Radiotherapy Plus Azidothymidine in Patients With AIDS-Related Lymph Node CancerTerminatedNCT00000723Not applicable
• Aerosols in the Treatment of Pneumocystis Pneumonia: A Pilot Study Quantitating the Deposition of Aerosolized Pentamidine as Delivered in ACTG 040 and Comparing Its Toxicity With Parenteral Pentamidine TherapyCompletedNCT00000722Not applicable
• An Escalating Dose Tolerance Trial of BG8962 (rCD4) in Patients Who Are HIV Antibody PositiveCompletedNCT00000721Phase 1
• A Double-Blind, Placebo-Controlled Trial To Evaluate Intravenous Gamma Globulin in Children With Symptomatic HIV Infection Receiving ZidovudineCompletedNCT00000720Phase 3
• A Trial of Alternating 2',3'-Dideoxycytidine and Zidovudine in the Treatment of Patients With Advanced HIV DiseaseCompletedNCT00000719Not applicable
• A Clinical Trial of Alternating and Intermittent Regimens of 2',3'-Dideoxycytidine and 3'-Azido-3'-Deoxythymidine in the Treatment of Patients With AIDS and Advanced ARCCompletedNCT00000718Not applicable
• The Safety and Efficacy of Clindamycin and Primaquine in the Treatment of Mild - Moderate Pneumocystis Carinii Pneumonia in Patients With AIDSCompletedNCT00000717Not applicable
• A Multicenter Trial To Evaluate Oral Retrovir in the Treatment of Children With Symptomatic HIV InfectionCompletedNCT00000716Phase 2
• A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral/Oral Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia in AIDSCompletedNCT00000715Phase 3
• An Open, Prospective, Multicenter Study of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia (PCP) and Serious Intolerance to Approved TherapiesCompletedNCT00000714Phase 3
• A Phase I Clinical Trial To Evaluate the Toxicity, Antiviral and Immunomodulatory Effects of a Range of Doses of Ampligen in HIV-Infected SubjectsCompletedNCT00000713Phase 1
• A Multicenter, Double Blind, Comparative Study of Zidovudine Alone Versus Zidovudine and Acyclovir as Treatment for HIV-Infected Patients With CD4+ Counts Less Than 200 Cells/mm3CompletedNCT00000712Phase 2
• Granulocyte-Macrophage Colony-Stimulating Factor and Zidovudine: A Phase I Study of Concurrent Administration in Patients With AIDS and Severe ARCCompletedNCT00000711Phase 1
• A Phase I Safety, Efficacy, and Pharmacokinetic Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Patients With AIDS or AIDS Related ComplexCompletedNCT00000710Phase 1
• An Open Trial of Zidovudine (AZT) Treatment of the AIDS Dementia Complex in Patients With AIDS or Low CD4+ Lymphocyte CountsCompletedNCT00000709Phase 3
• Multi-center Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal MeningitisCompletedNCT00000708Not applicable

← National Institutes of Health overview and focus areas